Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothyroidism | 1 | 2017 | 39 | 0.560 |
Why?
|
| Atrial Fibrillation | 9 | 2018 | 805 | 0.400 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2012 | 2 | 0.400 |
Why?
|
| Dobutamine | 1 | 2012 | 8 | 0.400 |
Why?
|
| Echoencephalography | 1 | 2012 | 13 | 0.400 |
Why?
|
| Exercise Test | 2 | 2012 | 242 | 0.370 |
Why?
|
| Myocarditis | 2 | 2021 | 60 | 0.300 |
Why?
|
| Catheter Ablation | 5 | 2010 | 145 | 0.280 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2005 | 96 | 0.230 |
Why?
|
| Electrocardiography | 4 | 2021 | 521 | 0.230 |
Why?
|
| Defibrillators, Implantable | 5 | 2021 | 257 | 0.220 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2008 | 34 | 0.200 |
Why?
|
| Giant Cells | 1 | 2021 | 15 | 0.180 |
Why?
|
| Heart Conduction System | 1 | 2000 | 50 | 0.170 |
Why?
|
| Fluoroscopy | 3 | 2008 | 62 | 0.170 |
Why?
|
| Heart Atria | 4 | 2008 | 135 | 0.160 |
Why?
|
| Algorithms | 2 | 2021 | 974 | 0.160 |
Why?
|
| Heart | 2 | 2021 | 274 | 0.160 |
Why?
|
| Pyrazoles | 1 | 2018 | 65 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2018 | 131 | 0.140 |
Why?
|
| Lyme Disease | 1 | 2017 | 104 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 628 | 0.100 |
Why?
|
| Humans | 19 | 2021 | 59366 | 0.100 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 74 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2008 | 1507 | 0.100 |
Why?
|
| Angiography | 2 | 2010 | 145 | 0.100 |
Why?
|
| Piperazines | 1 | 2012 | 74 | 0.100 |
Why?
|
| Pacemaker, Artificial | 2 | 2009 | 43 | 0.090 |
Why?
|
| Aged | 9 | 2018 | 13405 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2011 | 63 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 130 | 0.090 |
Why?
|
| Esophagus | 2 | 2007 | 50 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2008 | 275 | 0.080 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2009 | 24 | 0.080 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 42 | 0.080 |
Why?
|
| Bundle of His | 1 | 2008 | 3 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 67 | 0.070 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2008 | 9 | 0.070 |
Why?
|
| Male | 11 | 2018 | 27742 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 56 | 0.070 |
Why?
|
| Magnetics | 1 | 2008 | 53 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 111 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 21 | 0.070 |
Why?
|
| Mediastinum | 1 | 2007 | 27 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 205 | 0.060 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 253 | 0.060 |
Why?
|
| Electrodes, Implanted | 1 | 2006 | 37 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2006 | 176 | 0.060 |
Why?
|
| Amiodarone | 2 | 2005 | 20 | 0.060 |
Why?
|
| Ventricular Fibrillation | 1 | 2005 | 97 | 0.060 |
Why?
|
| Telemedicine | 1 | 2009 | 307 | 0.060 |
Why?
|
| Middle Aged | 9 | 2018 | 16310 | 0.050 |
Why?
|
| Tachycardia, Ventricular | 1 | 2005 | 119 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2008 | 206 | 0.050 |
Why?
|
| Endocardium | 1 | 2021 | 12 | 0.050 |
Why?
|
| Troponin I | 1 | 2021 | 34 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 52 | 0.040 |
Why?
|
| Procainamide | 1 | 2000 | 6 | 0.040 |
Why?
|
| Sodium Channel Blockers | 1 | 2000 | 10 | 0.040 |
Why?
|
| Heart Rate | 1 | 2002 | 307 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 98 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 410 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2021 | 162 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 129 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 365 | 0.040 |
Why?
|
| Pulmonary Veins | 2 | 2008 | 37 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2018 | 59 | 0.040 |
Why?
|
| Piperidines | 1 | 2018 | 55 | 0.040 |
Why?
|
| Adenine | 1 | 2018 | 49 | 0.040 |
Why?
|
| Heart Failure | 1 | 2006 | 853 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 1997 | 20 | 0.040 |
Why?
|
| Female | 8 | 2018 | 30719 | 0.040 |
Why?
|
| Lymphokines | 1 | 1997 | 65 | 0.040 |
Why?
|
| Hypotension | 1 | 1997 | 48 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2010 | 3067 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1997 | 146 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1997 | 169 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2008 | 525 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1306 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2008 | 5281 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 931 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5119 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 15679 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4273 | 0.020 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2008 | 33 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 29 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 72 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2008 | 126 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 153 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 180 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 216 | 0.020 |
Why?
|
| Aortography | 1 | 2007 | 55 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 403 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 88 | 0.020 |
Why?
|
| Contrast Media | 1 | 2008 | 400 | 0.020 |
Why?
|
| Sotalol | 1 | 2005 | 8 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 23 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2005 | 147 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 651 | 0.010 |
Why?
|
| Quality of Life | 1 | 2008 | 1137 | 0.010 |
Why?
|
| Chest Pain | 1 | 2002 | 81 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2002 | 99 | 0.010 |
Why?
|
| Sleep | 1 | 2002 | 215 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 3615 | 0.010 |
Why?
|
| Nitroarginine | 1 | 1997 | 2 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1997 | 10 | 0.010 |
Why?
|
| Diet, Atherogenic | 1 | 1997 | 7 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1997 | 8 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1997 | 19 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1997 | 19 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 45 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1997 | 33 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1997 | 28 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1997 | 49 | 0.010 |
Why?
|
| Vasodilation | 1 | 1997 | 35 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1997 | 68 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 322 | 0.010 |
Why?
|
| Aorta | 1 | 1997 | 108 | 0.010 |
Why?
|
| Swine | 1 | 1997 | 352 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1997 | 230 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1997 | 197 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 347 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 689 | 0.010 |
Why?
|
| Echocardiography | 1 | 1997 | 457 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2002 | 2516 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 6069 | 0.010 |
Why?
|
| Animals | 1 | 1997 | 19649 | 0.000 |
Why?
|